Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-606-1024
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Geoffrey Hill, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with Fred Hutch Cancer Center and UW Medicine/University of Washington Medical Center.
Education & Training
University of Auckland Faculty of Medicine and Health SciencesClass of 2001
Certifications & Licensure
WA State Medical License 2018 - 2026
Publications & Presentations
PubMed
- NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.Stephanie J Lee, Kirsten M Williams, Stefanie Sarantopoulos, Carrie L Kitko, Corey Cutler
Transplantation and Cellular Therapy. 2025-09-01 - Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT.Duneia McManus, Sabrina N Copsel, Brent J Pfeiffer, Dietlinde Wolf, Henry Barreras
Blood. 2025-08-01 - 1 citationsDeficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.Michael C Zaiken, Sujeong Jin, Cameron S McDonald-Hyman, Christina R Hartigan, Peter T Sage
Blood. 2025-06-12
Press Mentions
Tip Sheet: How a Failed Alzheimer’s Drug Boosts CAR T-cell Therapy; A New Type of Anti-CRISPR; And How GVHD Starts in the GutOctober 2nd, 2019
Grant Support
- Adult Leukemia Research CenterFRED HUTCHINSON CANCER CENTER1997–2029
- Defining Protective CMV Immunity after TransplantationFRED HUTCHINSON CANCER CENTER2023–2028
- Defining Protective CMV Immunity after TransplantationFRED HUTCHINSON CANCER CENTER2023–2028
- Preventing GVHD by inhibition of alloantigen presentation in the gutFRED HUTCHINSON CANCER CENTER2019–2027
